New York, NY, United States of America

Anu Daniel




Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Lexington, MA (US) (2014)
  • New York, NY (US) (2018 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anu Daniel

Introduction

Anu Daniel, an accomplished inventor based in New York, NY, has made significant strides in the field of bacteriophage research. With a total of four patents to her name, she focuses on innovative solutions to combat bacterial infections, particularly those caused by antibiotic-resistant bacteria.

Latest Patents

Among her latest patents, Anu has developed chimeric bacteriophage lysins that exhibit remarkable efficacy against staphylococcal populations. The first patent details a chimeric bacteriophage lysin engineered to effectively kill all tested strains of staphylococci, including antibiotic-resistant variants such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin intermediate Staphylococcus aureus (VISA). The second patent also relates to the use of chimeric bacteriophage lysins for identifying and reducing these pathogenic populations. Anu's innovations hold promise for addressing some of the pressing challenges in antibiotic resistance.

Career Highlights

Anu Daniel is currently associated with The Rockefeller University, a leading research institution that fosters scientific innovation. Her work is at the intersection of microbiology and biotechnology, and she has made notable contributions to the understanding of bacteriophages and their potential applications in treating bacterial infections.

Collaborations

Throughout her career, Anu has collaborated with esteemed colleagues, including Vincent A. Fischetti and Chad Euler. These partnerships have enhanced her research and contributed to the advancement of knowledge within the field of bacteriophage therapy.

Conclusion

Anu Daniel's innovative work represents a critical step forward in the fight against antibiotic-resistant bacteria. Her chimeric bacteriophage lysins not only showcase her expertise as an inventor but also highlight the potential for new therapeutic approaches to enhance public health. As she continues her research, Anu's contributions to science and innovation will undoubtedly inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…